Jane Mayotte

569 total citations
14 papers, 446 citations indexed

About

Jane Mayotte is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jane Mayotte has authored 14 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jane Mayotte's work include Molecular Biology Techniques and Applications (3 papers), HER2/EGFR in Cancer Research (3 papers) and Blood properties and coagulation (2 papers). Jane Mayotte is often cited by papers focused on Molecular Biology Techniques and Applications (3 papers), HER2/EGFR in Cancer Research (3 papers) and Blood properties and coagulation (2 papers). Jane Mayotte collaborates with scholars based in United States, Spain and Ireland. Jane Mayotte's co-authors include Anna Lokshin, Wendong Lei, M. Rizwan Sohail, Reece Holbrook, Kurt Stromberg, Mikhael F. El‐Chami, Laurence M. Epstein, Mark L. Levitt, Jason Christiansen and Melissa A. Cregger and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Biochemical and Biophysical Research Communications.

In The Last Decade

Jane Mayotte

14 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Mayotte United States 11 159 158 94 73 70 14 446
Sebastian Ebel Germany 10 126 0.8× 163 1.0× 63 0.7× 83 1.1× 111 1.6× 33 363
C. Chow United States 9 167 1.1× 260 1.6× 20 0.2× 60 0.8× 64 0.9× 11 434
Li Ren China 14 172 1.1× 250 1.6× 64 0.7× 129 1.8× 127 1.8× 31 610
Rick D. Holly United States 7 163 1.0× 94 0.6× 50 0.5× 35 0.5× 49 0.7× 10 648
Valérie Breton Canada 9 264 1.7× 147 0.9× 49 0.5× 42 0.6× 50 0.7× 16 517
Marina Cardillo United States 13 229 1.4× 238 1.5× 23 0.2× 117 1.6× 37 0.5× 16 572
Melisa W-Y. Ho United States 5 255 1.6× 193 1.2× 17 0.2× 130 1.8× 108 1.5× 10 586
Isha Kapoor India 13 376 2.4× 141 0.9× 24 0.3× 35 0.5× 81 1.2× 25 569
Nathalie Dugot‐Senant France 13 375 2.4× 119 0.8× 19 0.2× 63 0.9× 157 2.2× 30 670
Ugo Déry Canada 12 858 5.4× 437 2.8× 101 1.1× 72 1.0× 70 1.0× 18 1.1k

Countries citing papers authored by Jane Mayotte

Since Specialization
Citations

This map shows the geographic impact of Jane Mayotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Mayotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Mayotte more than expected).

Fields of papers citing papers by Jane Mayotte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Mayotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Mayotte. The network helps show where Jane Mayotte may publish in the future.

Co-authorship network of co-authors of Jane Mayotte

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Mayotte. A scholar is included among the top collaborators of Jane Mayotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Mayotte. Jane Mayotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
El‐Chami, Mikhael F., Reece Holbrook, Kurt Stromberg, et al.. (2020). Leadless pacemakers reduce risk of device-related infection: Review of the potential mechanisms. Heart Rhythm. 17(8). 1393–1397. 95 indexed citations
2.
El‐Chami, Mikhael F., et al.. (2020). Reduced bacterial adhesion with parylene coating: Potential implications for Micra transcatheter pacemakers. Journal of Cardiovascular Electrophysiology. 31(3). 712–717. 22 indexed citations
3.
Sindberg, Gregory M., et al.. (2018). Micro-CT imaging as a method for comparing perfusion in graduated-height and single-height surgical staple lines. Medical Devices Evidence and Research. Volume 11. 267–273. 10 indexed citations
4.
Gustavson, Mark, Melissa A. Cregger, Jane Mayotte, et al.. (2009). Standardization of HER2 immunohistochemistry in breast cancer by automated quantitative analysis.. Archives of Pathology & Laboratory Medicine. 133(9). 1413–1419. 46 indexed citations
5.
Jones, Courtney L., et al.. (2009). Evaluation of the false-negative rate of standardized and quantitative measurement of estrogen receptor (ER) in tissue using AQUA technology. Journal of Clinical Oncology. 27(15_suppl). 567–567. 1 indexed citations
6.
Gustavson, Mark, Melissa A. Cregger, Jane Mayotte, et al.. (2009). Standardization of HER2 Immunohistochemistry in Breast Cancer by Automated Quantitative Analysis. Archives of Pathology & Laboratory Medicine. 133(9). 1413–1419. 45 indexed citations
7.
LaRochelle, William J., Michael Jeffers, José R. F. Corvalán, et al.. (2002). Platelet-derived growth factor D: tumorigenicity in mice and dysregulated expression in human cancer.. PubMed. 62(9). 2468–73. 50 indexed citations
8.
Lokshin, Anna, et al.. (2000). Early effects of retinoic acid on proliferation, differentiation and apoptosis in non-small cell lung cancer cell lines.. PubMed. 19(6B). 5251–4. 16 indexed citations
9.
Koty, Patrick P., et al.. (1999). Induction of Multiple Programmed Cell Death Pathways by IFN-β in Human Non-Small-Cell Lung Cancer Cell Lines. Experimental Cell Research. 247(1). 133–141. 20 indexed citations
10.
Lei, Wendong, et al.. (1999). Enhancement of chemosensitivity and programmed cell death by tyrosine kinase inhibitors correlates with EGFR expression in non-small cell lung cancer cells.. PubMed. 19(1A). 221–8. 53 indexed citations
11.
Lei, Wendong, Jane Mayotte, & Mark L. Levitt. (1998). EGF-Dependent and Independent Programmed Cell Death Pathways in NCI-H596 Nonsmall Cell Lung Cancer Cells. Biochemical and Biophysical Research Communications. 245(3). 939–945. 14 indexed citations
12.
Lokshin, Anna, et al.. (1995). Mechanism of Interferon Beta-Induced Squamous Differentiation and Programmed Cell Death in Human Non--Small--Cell Lung Cancer Cell Lines. JNCI Journal of the National Cancer Institute. 87(3). 206–212. 54 indexed citations
13.
Nair, Suresh, et al.. (1994). Induction of Squamous Differentiation by Interferon beta in a Human Non-Small-Cell Lung Cancer Cell Line. JNCI Journal of the National Cancer Institute. 86(5). 378–383. 12 indexed citations
14.
Sabatini, Linda M., et al.. (1994). PHENOTYPIC, MOLECULAR AND GENETIC-CHARACTERIZATION OF TRANSFORMED HUMAN BRONCHIAL EPITHELIAL-CELL STRAINS. International Journal of Oncology. 4(2). 461–70. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026